Form 4: Align Technology Director Anne Myong Equity Update

Director Anne Myong acquired 1,745 shares of Align Technology common stock through the vesting of restricted stock units.

Summary

• Director Anne Myong acquired 1,745 shares of Align Technology (ALGN) common stock on May 20, 2026, following the vesting of restricted stock units (RSUs).
• The transaction resulted in a total direct beneficial ownership of 9,830 shares of common stock.
• A new grant of 1,836 RSUs was awarded to the director on May 20, 2026, scheduled to vest on May 20, 2027, or the date of the next annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation with no impact on company operations or financial strategy.

Positives

• Director maintains a significant equity stake of 9,830 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• Future vesting of the 1,836 newly granted RSUs is contingent upon the director's continued service to the company.

Future Outlook

The director received a new grant of 1,836 RSUs which are expected to vest on May 20, 2027, subject to continued service.

Management Comments

• The transaction reflects standard equity compensation vesting and grant cycles for company directors.

Industry Context

StockSavvy.ai notes that this filing represents routine director equity compensation, which is standard practice for publicly traded companies in the medical device and dental technology sector to ensure board alignment with long-term shareholder value.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard corporate governance practices for S&P 500 companies.
• Director ownership levels are typical for non-executive board members in the healthcare technology industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of 1,836 RSUs on May 20, 2027.

Key Dates

Keywords

Align Technology, ALGN, Form 4, Insider Trading, Equity Compensation, Director Ownership